To amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations.

Bill 119 HR 2111, also known as the Premium Cigar Exemption Act, aims to make changes to the Federal Food, Drug, and Cosmetic Act in order to provide exemptions for the premium cigar industry from certain regulations. The bill seeks to specifically exempt premium cigars from regulations that were put in place by the Food and Drug Administration (FDA) in 2016.

The bill argues that premium cigars are a unique product that should not be subject to the same regulations as other tobacco products, such as cigarettes and e-cigarettes. Supporters of the bill believe that premium cigars are enjoyed by adults in moderation and do not pose the same health risks as other tobacco products.

If passed, the Premium Cigar Exemption Act would provide relief to small businesses in the premium cigar industry, who have been burdened by the regulations put in place by the FDA. The bill has garnered support from members of Congress who believe that the regulations on premium cigars are unnecessary and harmful to the industry. Opponents of the bill argue that exempting premium cigars from regulations could have negative health consequences, as cigars still contain harmful substances that can lead to addiction and other health issues. They believe that all tobacco products should be subject to the same regulations in order to protect public health. Overall, Bill 119 HR 2111 seeks to provide exemptions for the premium cigar industry from certain regulations in order to support small businesses and preserve the unique nature of premium cigars. The bill has sparked debate among lawmakers and stakeholders, with both supporters and opponents voicing their opinions on the potential impact of the legislation.